Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 16, 2021

SELL
$0.94 - $1.89 $4,199 - $8,444
-4,468 Closed
0 $0
Q3 2020

Nov 17, 2020

SELL
$1.5 - $9.38 $165,000 - $1.03 Million
-110,000 Reduced 96.1%
4,468 $8,000
Q3 2020

Nov 13, 2020

BUY
$1.5 - $9.38 $165,000 - $1.03 Million
110,000 Added 2461.95%
114,468 $206,000
Q2 2020

Aug 17, 2020

BUY
$4.79 - $8.39 $21,401 - $37,486
4,468 New
4,468 $37,000

Others Institutions Holding CRBP

About Corbus Pharmaceuticals Holdings, Inc.


  • Ticker CRBP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 125,268,000
  • Market Cap $2.08B
  • Description
  • Corbus Pharmaceuticals Holdings, Inc., a biopharmaceutical company, focuses on the development of immune modulators for immuno-oncology and fibrosis diseases. It develops lenabasum, an oral molecule that selectively activates cannabinoid receptor type 2 (CB2), which is in Phase II clinical trial to treat systemic lupus erythematosus; CRB-601, an...
More about CRBP
Track This Portfolio

Track Great West Life Assurance CO Portfolio

Follow Great West Life Assurance CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Great West Life Assurance CO , based on Form 13F filings with the SEC.

News

Stay updated on Great West Life Assurance CO with notifications on news.